 Home > Medical News > Pharmaceutical Marketing > The bivalent vaccine and the infant vaccine are expected to arrive in Macao within this month

The bivalent vaccine and the infant vaccine are expected to arrive in Macao within this month

 Last Update: 2023-01-05
 Source: Internet
 Author: User

Tags

fda government agency

meningitis vaccine ingredients

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The Health Bureau of the Macao SAR Government said on the 21st that the BioNTech bivalent mRNA vaccine and the new crown vaccine dosage form for young children are expected to arrive in Macao
within this month.

According to reports, in response to the epidemic caused by the new coronavirus Omicron variant, the Macao SAR government has purchased the BioNTech bivalent mRNA vaccine, which according to the data, is temporarily approved for booster doses
for people aged 12 or above.

In addition, the HKSAR Government has also purchased BioNTech mRNA vaccine dosage forms for children aged 6 months to 4 years, which contain the same ingredients as adult dosage forms, but at lower
doses.

According to the latest notice from suppliers, the above two new coronavirus vaccines are expected to arrive in Macao within this month, and the Health Bureau will arrange vaccination for the public upon arrival
.

The Macao Novel Coronavirus Response and Coordination Center announced on the 21st that Macao added one new imported associated case found in the control on the same day, a 58-year-old female Mainland resident, who is a family member
of a confirmed imported new coronavirus case (60-year-old mainland traveler) announced a few days ago.
The Response Coordination Centre announced that all persons entering Macao from the Mainland are required to undergo a nucleic acid test
in Macao the day after entry.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Pharmaceutical Intermediate API Raw Material 6-Diazo-5-Oxo-L-Norleucine Pure 98% CAS 157-03-9

CAS No.: 157-03-9

Pharmacy Grade

$600.00/G EXW

Pro-xylane CAS NO. 439685-79-7

CAS No.: 439685-79-7

Pharmacy Grade

$270-350/G FOB

tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate

CAS No.: 571188-59-5

API Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.